Dr. Vincent DeOrchis interviewed by WPIX’s Marvin Scott regarding the first patient in the U.S. treated with an experimental therapy developed by NKGen Biotech for advanced Alzheimer’s type dementia
Promising new treatment for advanced Alzheimer’s patients
NEW YORK (PIX11) — It’s estimated that more than six million Americans have Alzheimer’s, a degenerative disease that is the seventh leading cause of death in the U.S.
With no known cure, it’s feared that with an aging population, the numbers will rise significantly in the coming years. Researchers are developing and testing new treatments they hope will improve the quality of life of ailing patients.
Continue reading at:
